Several HLA types have been found to be associated with diseases and pharmacogenetics. Expensive and time-consuming technologies, such as SSP and SSOP are still used to test such associations, but at GenDx we believe that innovation is the key for more reliable and efficient disease association screenings.
This is why we put a lot of effort to develop a new product: NGSgo®-HLALinkX. It is fully compatible with our NGSgo® HLA typing strategy and it will reduce your laboratory workload and will make your NGS runs more cost-effective.
You have an opportunity to become among the first users of NGSgo®-HLALinkX by participating in the Early Access Program and testing the product!